Latest news with #ApolloCancerCentre
Time of India
5 days ago
- Health
- Time of India
Apollo Hospitals launches ‘End-O Check' to boost early detection of cancers
CHENNAI: Apollo Cancer Centre (ACC) and Apollo Proton Cancer Centre (APCC) have launched 'End-O Check', a specialised screening and diagnostic initiative for the early detection of ovarian and endometrial cancers in women, particularly those in the postmenopausal age group. Tired of too many ads? go ad free now The programme, unveiled on July 30, offers risk-based assessments, diagnostic tests, and symptom evaluation to enable early identification of two of the most prevalent gynaecological cancers. Doctors say timely diagnosis can drastically improve survival outcomes, especially in the case of ovarian cancer, often dubbed the 'silent killer,' which is typically diagnosed at an advanced stage. Speaking at the launch, Dinesh Madhavan, president, group oncology & international, Apollo Hospitals, said, 'Early detection remains our most powerful ally in improving survival and quality of life. End-O Check is a proactive step towards shifting the narrative to early diagnosis and precision treatment.' A panel discussion held alongside the launch featured senior oncologists including Dr Ajit Pai, Dr Venkat P, Dr Kumar Gubbala, Dr Madhu Priya and Dr Priya Kapoor. The session emphasised the need for greater awareness, timely intervention, and busting myths that deter women from seeking early care. According to the doctors, India's cancer burden is projected to rise to 1.57 million cases by 2025, with ovarian and uterine cancers among the top five affecting women. The age-standardized incidence rate for ovarian cancer is 4.6 per 100,000 and 2.5 for uterine cancers. 'Reproductive pattern changes, urban lifestyles, and increasing metabolic conditions are all contributing to the rise,' said Dr Kumar Gubbala, consultant – gynaecologic oncology, APCC. Endometrial cancer, though more likely to present symptoms like unexpected bleeding or abnormal discharge, often goes unreported until it's too late, doctors said. Tired of too many ads? go ad free now 'End-O Check is more than just screening—it's about awareness and access,' said Karan Puri, CEO, Apollo Cancer Centres & APCC. 'When cancers are caught early, the treatments are often simpler, less invasive, and significantly more effective,' he said. Apollo officials said the programme would be rolled out across its cancer centres and it would include both clinical consultations and public education efforts, aiming at empowering more women to take proactive steps toward their gynaecologic health.
The Hindu
30-07-2025
- Health
- The Hindu
Apollo launches ‘End-O Check' for early detection of ovarian cancer
Apollo Cancer Centre (ACC) and Apollo Proton Cancer Centre (APCC) launched End-O Check, an early detection programme for ovarian and endometrial cancers. Targetting postmenopausal women and those in high-risk groups, the initiative combines risk-based assessments, symptom evaluation, and diagnostic testing. At the launch, a panel discussion brought together experts from Apollo centres to stress the need for awareness, early diagnosis, and access to preventive tools. The panel featured Ajit Pai, senior consultant, surgical oncology, ACC-Teynampet, P. Venkat, senior consultant, surgical oncology, ACC-Teynampet, Kumar Gubbala, consultant, gynaecological oncology, APCC, Madhu Priya, senior consultant, surgical oncology, ACC-Vanagaram, and Priya Kapoor, consultant, surgical oncology, ACC-Teynampet. The discussion was moderated by Ayyappan, senior consultant, surgical oncology, ACC-Teynampet. Ovarian cancer, often termed a silent killer, typically affects women between 55 and 64 years. Early-stage detection can push survival rates beyond 90%, but vague symptoms often delay diagnosis. Endometrial cancer, on the other hand, frequently presents with signs such as abnormal bleeding, yet many women fail to seek timely care. Dr. Madhu Priya also highlighted the importance of ovum preservation for younger women undergoing cancer treatment. 'Freezing eggs for fertility preservation gives women the option to protect their ability to have biological children after cancer treatment. Including this as part of cancer care supports informed, compassionate, and holistic treatment planning,' she said. Dinesh Madhavan, President, Group Oncology and International, Apollo Hospitals, called the initiative a shift from treatment to early detection. With India's cancer burden projected to rise, End-O Check seeks to help women to take charge of their gynaecologic health through education, screening as well as early intervention.
Time of India
30-07-2025
- Health
- Time of India
Early detection prog for endometrial, ovarian cancer in women launched
Mysuru: Surgery is the primary treatment for two of the most prevalent gynaecological cancers, Apollo BGS Hospitals surgical oncologist Dr Y Ramya said on Wednesday. She highlighted that advances in minimally invasive surgery and cytoreductive surgery have helped patients to have a faster and better recovery. Speaking to reporters during the launch of Apollo Cancer Centre's End-O Check, a comprehensive early detection programme targeting women aged 45 and above, she stated that the initiative is designed to detect endometrial and ovarian cancer at an early and more treatable stage. Ovarian cancer is a silent killer as the majority of women come to the hospital only in the advanced stage due to non-specific early symptoms. "Endometrial cancers can be picked up very early due to early presentation. Still, patients approach us in late stages due to negligence or lack of awareness. Both cancers are curable if detected and treated in the early stages," Ramya said. Dr Vanitha LV, senior consultant–obstetrics & gynaecology at Apollo BGS Hospitals, said, "Endometrial cancer has been on the rise in women above the age of 45 years, so early detection is crucial for better outcomes. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like LeafFilter turns your gutter to-dos … to done. LeafFilter Gutter Protection Learn More Undo Global data indicates a five-year survival rate of around 96% for localised disease. Key risk factors include obesity, diabetes, early menstruation, and late menopause, all of which are becoming more prevalent among Indian women. " Dr Naveen Jayaram, consultant medical oncologist, said, "Ovarian cancer is the third most common cancer in India, with a younger median age of diagnosis (50–56 years) compared to the West (around 63 years). Over 70% of Indian women are diagnosed at an advanced stage due to vague early symptoms and lack of effective screening. Common symptoms include abdominal pain, bloating, and gastrointestinal issues. Advanced-stage survival averages 20-30 months, while early-stage survival can exceed 80%. " Dr Ranjitha V N, consultant oncopathologist, was present.
Time Business News
25-07-2025
- Health
- Time Business News
Breakthrough Innovations Transforming Lung Cancer Diagnosis and Treatment
Lung cancer is a type of cancer that begins in the lungs, often caused by smoking, exposure to pollutants, genetic factors or commercial threats. Lung cancer market is increasing due to growing global lung cancer rate, awareness and increase in screening programs, progress in clinical technologies (such as low -dosage CT scans and liquid biopsy) and increasing remedies and development of targeted remedies and immunotherapy. Additionally, better healthcare in aging population and emerging areas is promoting infrastructure and early detection and demand for effective treatment solutions. Key Growth Drivers and Opportunities Growing Global Lung Cancer Rate: Rising global lung cancer rate is a major driver of lung cancer market development, as it increases the demand for early identity, accurate diagnosis and effective treatment solutions. One of the major causes of cancer-related deaths worldwide with lung cancer, healthcare systems are making heavy investments in advanced screening tools such as low-dosage CT scans and biomarker-based diagnosis to enable the first diagnosis. At the same time, rising patient numbers are accelerating the development and adoption of innovative remedies including targeted drugs and immunotherapy. The burden of growing disease also attracts more research funds and industry investment, further fuel to market expansion. Challenges The lung cancer market faces several borders, including advanced diagnosis and high cost of targeted treatments, which can limit access to areas with especially low and moderate income. Delayed diagnosis also disrupts the results of treatment due to lack of awareness, limited screening programs and non-specific initial symptoms. Additionally, the challenge of complex regulatory routes, delayed stage patients, and the challenge of managing side effects from therapy disrupts the market growth despite technological progress. Innovation and Expansion EQUAL Study Launches High-Risk Group Lung Cancer Screening Trial In May 2025, Researchers at the Dana-Farber Cancer Institute have begun testing a new, in-house blood test in an effort to screen for lung cancer and identify those who are at a higher risk of developing the disease even if they have never used tobacco. Epidermal growth factor receptor (EGFR) gene mutations can be common in the Asian and Hispanic/Latinx populations, which is the subject of the EQUAL (EGFR ctDNA Quantitative Assessment for Lung Cancer screening in Asian and Latinx populations) study. Possessing this mutation increases the risk of lung cancer because EGFR type mutations are linked to the illness. Additionally, the number of cancer diagnoses among Asian or Hispanic/Latinx individuals is increasing at a faster rate. With India's First LungLife Screening Program to Fight Lung Cancer, Apollo Cancer Centre Sets the Standard In March 2025, India's first LungLife Screening Program for early lung cancer diagnosis has been introduced by Apollo Cancer Centres (ACCs), a pioneer in state-of-the-art cancer care. Lung cancer, which makes up 5.9% of all malignancies and 8.1% of cancer-related deaths in India, is the target of this ground-breaking project. Early identification increases the survival rate and improves treatment results (LINK). Low-dose computed tomography (LDCT) early screening can greatly increase survival chances and help with early diagnosis. However, almost 80% of high-risk patients have never spoken to their doctors about screening. To allow early detection and save lives, it is imperative to improve knowledge and communication regarding lung cancer screening, particularly among high-risk individuals. Inventive Sparks, Expanding Markets The key players operating the lung cancer market include AstraZeneca, Hoffman La Roche, Eli Lilly and Company, Pfizer Inc., Merck & Co., Amgen Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceuticals Industries Ltd., Bristol-Myers Squibb Company. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
United News of India
30-05-2025
- Health
- United News of India
ACC introduces screening program for early detection of Oral Cancer
Hyderabad, May 30 (UNI)Apollo Cancer Centres (ACC) on World No Tobacco Day,(ACC) launched #OraLife, a proactive screening initiative focused on the early detection of oral cancer on Friday. The program emphasizes public awareness, routine screening, and targeted intervention particularly for high-risk individuals, including tobacco users, alcohol consumers, those with HPV-16 infection, and people with prior oral lesions. As part of this initiative, ACC has partnered with the Isha Foundation to provide holistic support for individuals seeking to overcome tobacco addiction. This collaboration integrates physical health interventions with mental and emotional wellness support. 'Tobacco users are six to seven times more likely to develop oral cancer than cancer is one of the few cancers that can be detected early through a simple oral examination. With this program, our goal is to detect cases early—before it's too late.' said Dr. Umanath Nayak Senior Consultant Head and Neck Oncology Surgeon at Apollo Cancer Centre. Oral cancer is the most common cancer among Indian men and is rising steadily among women. Incidence rates vary widely across states: West Bengal reports the highest, while Kerala sees the lowest. Maharashtra, Ahmedabad Urban, and Meghalaya also report alarmingly high figures—largely driven by tobacco use. Chennai-based studies have identified an increase in cancers of the tongue base and floor of the mouth, sites known for high metastatic potential. The buccal mucosa remains the most frequently affected site nationwide. Notably, smokeless tobacco use is rising among women, contributing to a narrowing gender gap in incidence rates. Risk factors—such as the combined use of smokeless tobacco, betel quid, and alcohol—are especially prevalent in underserved communities with limited access to preventive care. The disease is increasingly affecting individuals aged 31–50, with poor nutrition further exacerbating the risk. 'Our objective is to foster a culture of preventive healthcare. Oral cancer is highly treatable when detected early. We urge everyone over 30, especially tobacco users to undergo screening.' said Dr. Arsheed Hakeem Consultant - Head & Neck Surgical Oncology, Apollo Cancer Centre, Jubilees Hills, Hyderabd. The #OraLife, the Oral Cancer Screening Program, involves a comprehensive visual and tactile oral examination conducted by trained medical oncologists and head & neck surgeons. It aims to identify early warning signs such as persistent ulcers, red or white patches, lumps, and non-healing sores—many of which are often overlooked. Apollo has teamed up with the Isha Foundation to incorporate spiritual well-being into its tobacco cessation efforts. As part of this, individuals will have access to a simple, yet effective 7-minute guided meditation led by Sadhguru. 'Miracle of Mind' is a free meditation app that empowers individuals to take charge of their well-being. ' Our collaboration with Isha Foundation is a testament to our belief in integrated care, where early detection and mental wellness are both critical pillars.' Dr. Abhishek Budharapu, - Head & Neck Surgical Oncology, Apollo Cancer Centre said. Research indicates that tobacco users spend over Rs 1.1 lakh more on healthcare over their lifetime compared to non-users. The consequences extend beyond health—tobacco use reduces life expectancy, raises insurance premiums, limits claim payouts, and destabilizes families, particularly when primary earners are affected. UNI KNR BD
